top of page
ABOUT
Hylomorph is a Medtech Startup company, spin-off of the Swiss Federal Institute of Technology.
We specialize in cutting-edge combination of micro-engineering and biotechnology into innovative biomaterials for healthcare products.
​
Hylomorph's core technology optimizes the interface between implantable medical devices and the biological tissues.
​
Our headquarter is based at Technopark Zurich, in the heart of Switzerland.
​
Curious to know more about what we do? Click below and listen to Hylomorph CEO, Dr. Simone Bottan.
TEAM
Credits: Lichtsteiner Foundation
BOARD OF DIRECTORS
AWARDS AND SUPPORT








Co-funded by the Horizon 2020 programme of the European Union
bottom of page